Safety and immunogenicity of sequential administration of PCV13 followed by PPSV23 in pneumococcal vaccine-naïve adults aged ≥ 65 years: Comparison of booster effects based on intervals of 0.5 and 1.0 year-Reference-Cited by-同舟云学术

Safety and immunogenicity of sequential administration of PCV13 followed by PPSV23 in pneumococcal vaccine-naïve adults aged ≥ 65 years: Comparison of booster effects based on intervals of 0.5 and 1.0 year

Published:2023-01 Issue:5 Volume:41 Page:1042-1049
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Azuma Momoyo,Oishi Kazunori,Akeda Yukihiro,Morino Saeko,Motoki Yumi,Hanibuchi Masaki,Nishioka Yasuhiko

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference27 articles.

1. Pneumococcal infection in adults: burden of disease;Drijkoningen;Clin Microbiol Infect,2014

2. Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013–2019;Tamura;Vaccine,2022

3. Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in Alaska native adults 55–70 years of age;Miernyk;Clin Infect Dis,2009

4. Sequential administration of Prevnar 13TM and PNEUMOVAXTM 23 in healthy participants 50 years of age and older;Buchwald;Hum Vaccin Immunother,2021

5. Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia;Musher;J Infect Dis,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal interval for the administration of a pneumococcal polysaccharide vaccine following the administration of a pneumococcal conjugate vaccine;Vaccine;2024-04

2. Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature;Human Vaccines & Immunotherapeutics;2023-11-28

3. The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus;European Respiratory Review;2023-09-06

4. Emerging vaccine strategies against the incessant pneumococcal disease;npj Vaccines;2023-08-17